MedTrace Logo

Intensive Therapy for Children With Microcephaly, Hyperkinetic Movements, or Global Developmental Delay

NCT04816175 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2022-10-13

No results posted yet for this study

Summary

This trial will consist of a clinical series of up to 50 children with Global Developmental Delay and concomitant microcephaly or hyperkinetic movements. All children will be assessed for psychomotor function using standardized assessments, goal specific assessments, with the potential addition of neuroimaging assessment, prior to and after receiving an intensive burst of neuromotor therapy. The interventional effects will be explored by comparing the pre and post interventional assessments and neuroimaging.

Conditions

  • Microcephaly
  • Hyperkinesis With Developmental Delay
  • Global Developmental Delay

Interventions

BEHAVIORAL

Acquire Therapy

This intervention is an operant conditioning based neurorehabilitation protocol for the promotion of psychomotor function

Sponsors & Collaborators

  • American Academy of Cerebral Palsy and Developmental Medicine

    collaborator OTHER

  • Virginia Polytechnic Institute and State University

    lead OTHER

Principal Investigators

  • Stephanie C DeLuca, PhD · Virginia Polytechnic Institute and State University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
6 Months
Max Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-30
Primary Completion
2021-12-30
Completion
2022-08-11

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04816175 on ClinicalTrials.gov